Delft, Netherlands

Ingrid Francisca Caroline Van Der Wildt

This inventor holds 1 USPTO granted patent. Top assignee: Dsm N.v.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingrid Francisca Caroline Van Der Wildt. Retrieved from https://idiyas.com/inventor/ingrid-francisca-caroline-van-der-wildt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ingrid Francisca Caroline Van Der Wildt

Introduction

Ingrid Francisca Caroline Van Der Wildt is a notable inventor based in Delft, Netherlands. He has made significant contributions to the field of microbial biotechnology, particularly in the production of sphingolipid bases. His work has implications for various applications in health and industry.

Latest Patents

Ingrid holds a patent for "Microbial strains producing sphingolipid bases." This patent discloses microbial strains capable of producing enhanced levels of sphingosine, dihydrosphingosine, phytosphingosine, and their derivatives. The patent also outlines methods based on mutagenesis and other selection techniques to produce such strains. Notably, mutant strains of Pichia are provided, which can produce about 50% or more of these compounds compared to wild-type strains.

Career Highlights

Ingrid is associated with DSM N.V., a company known for its focus on health, nutrition, and materials. His work at DSM N.V. has allowed him to explore innovative solutions in biotechnology and contribute to advancements in the field.

Collaborations

Ingrid collaborates with Lex De Boer, enhancing the research and development efforts within their projects. Their combined expertise fosters innovation and drives progress in microbial biotechnology.

Conclusion

Ingrid Francisca Caroline Van Der Wildt's contributions to microbial biotechnology, particularly through his patent on sphingolipid-producing strains, highlight his role as an influential inventor. His work continues to pave the way for advancements in health and industry applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…